A genetic variant of Fc?RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer.
A genetic variant of Fc?RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics. 2013 Feb; 65(2):91-6.